[ad_1]
The Sunday Times reports that "half of the patients went into remission after being treated with the battery-powered device.The researchers claim that it could potentially revolutionize mental health care and could save millions of pounds in the service. health".
More than 100 research studies have demonstrated the effectiveness of Alpha-Stim. United States, the NHS sought to examine not only the clinical effectiveness of the device, but also the cost-effectiveness of its use in the single-payer UK health system. Alpha-Stim has proven to be a profitable choice with a saving of £ 540 ($ 680) per patient, compared to other available treatments.
In addition to Alpha-Stim, only 28% of participants required additional treatment. According to Dr. Richard Morriss, principal investigator of the study and professor of psychiatry at the University of Nottinghamthis could significantly reduce the workload related to improving access to psychological treatment services (IAPT) in England which considers GAD as one of two common problems with 4.4% of the UK population affected.
"Alpha-Stim CES has been more effective than expected in remission.In addition to the improvement of anxiety, there have been improvements in depression and insomnia," said the Dr. Morriss in The Sunday Times.
Given that 25% of the European population suffers from depression or anxiety and that universal services such as mental health are largely funded by taxes in European healthcare systems, a saving of more than £ 540 per patient represents a considerable gain.
The results obtained with Alpha-Stim in the NHS study prove that this neuromodulation treatment is a valuable alternative or an adjunct to psychological treatment.
An article in Woman and Home pointed out that the "Alpha-Stim" might be a useful alternative to treatment, for people looking for a different option – or for those who are not satisfied with the treatment. long waiting times for the NHS, often badociated with anxiety treatments Patients waiting for CBT can often wait more than eight weeks.A faster and at home option would probably be welcome. "
As a result of this groundbreaking research, News from the sky profile Steve Hutchinson, father of four, suffering from anxiety, insomnia and depression until the discovery of Alpha-Stim. "The change has been amazing in terms of quality of life, which has allowed me to do things that I might have had trouble doing otherwise." Although Hutchinson did not participate in the study, his findings match those found during the research.
In an accompanying article in The Sunday Times, victim of violent badual badault, "After using the Alpha-Stim device, I do not jump out of all the shadows and all the sounds." She reveals how, after being traumatized for 16 years, she finally finds relief.
About Alpha-Stim®
Alpha-Stim® is a non-invasive medical prescription device (no prescription required outside the United States) that is authorized by the FDA to provide prompt, safe and effective treatment for anxiety, insomnia, depression and pain. The brain functions electrochemically and can be easily modified by electrical intervention. The Alpha-Stim AID uses cranial electrostatic stimulation (CES) to provide the only patented waveform that has been clinically proven to significantly reduce anxiety and depression. concurrent. Alpha-Stim M uses CES to treat mood and sleep, as well as electrical microcurrent therapy (MET), as well as to treat pain. Alpha-Stim can be used alone, in combination with other treatments, or in addition to a drug (without the risk of drug interaction). There are no serious side effects, no risk of addiction, and over 100 38-year research studies that prove the effectiveness of this low-level electrical prescribing cerebral therapy.
Manufactured by Electromedical Products International, Inc., Alpha-Stim products and accessories are FDA approved in United States for marketing, have obtained CE marking for regulatory approval Europe (via the European Medical Devices Directive), has obtained the UL (Underwriter & # 39; s Laboratory) safety list, approved by TGA (Australia) and is approved throughout Asia, including China, Japanand in Korea – and in most countries of the world.
For more information, call 1-800-FOR-PAIN or visit www.alpha-stim.com.
Full Disclosure of Minor and Self-Resolving Risks at www.alpha-stim.com/risk.
SOURCE Electromedical Products International, Inc.
Source link
